351 related articles for article (PubMed ID: 30315141)
1. Prognostic Value of Cancer Stem Cell Markers in Potentially Malignant Disorders of Oral Mucosa: A Meta-analysis.
Saluja TS; Ali M; Mishra P; Kumar V; Singh SK
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):144-153. PubMed ID: 30315141
[TBL] [Abstract][Full Text] [Related]
2. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
[TBL] [Abstract][Full Text] [Related]
3. Could salivary biomarkers be useful in the early detection of oral cancer and oral potentially malignant disorders, and is there a relationship between these biomarkers and risk factors?
Elmahgoub F
Evid Based Dent; 2022 Mar; 23(1):30-31. PubMed ID: 35338326
[TBL] [Abstract][Full Text] [Related]
4. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.
Chiou SH; Yu CC; Huang CY; Lin SC; Liu CJ; Tsai TH; Chou SH; Chien CS; Ku HH; Lo JF
Clin Cancer Res; 2008 Jul; 14(13):4085-95. PubMed ID: 18593985
[TBL] [Abstract][Full Text] [Related]
5. Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan.
Yu JS; Chen YT; Chiang WF; Hsiao YC; Chu LJ; See LC; Wu CS; Tu HT; Chen HW; Chen CC; Liao WC; Chang YT; Wu CC; Lin CY; Liu SY; Chiou ST; Chia SL; Chang KP; Chien CY; Chang SW; Chang CJ; Young JD; Pao CC; Chang YS; Hartwell LH
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11549-11554. PubMed ID: 27663741
[TBL] [Abstract][Full Text] [Related]
6. A novel 4-gene signature model simultaneously predicting malignant risk of oral potentially malignant disorders and oral squamous cell carcinoma prognosis.
Zhang X; Yang M; Liu Y; Liu H; Yang J; Luo J; Zhou H
Arch Oral Biol; 2021 Sep; 129():105203. PubMed ID: 34252587
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical Expression of Epidermal Growth Factor Receptor (EGFR) in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Aamir R; Rauf F; Iqbal F; Yousuf S; Rehman A; Sheikh AK; Muhammad S
Appl Immunohistochem Mol Morphol; 2024 Mar; 32(3):157-162. PubMed ID: 38268382
[TBL] [Abstract][Full Text] [Related]
8. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
[TBL] [Abstract][Full Text] [Related]
9. CSC
Ortiz RC; Amôr NG; Saito LM; Santesso MR; Lopes NM; Buzo RF; Fonseca AC; Amaral-Silva GK; Moyses RA; Rodini CO
Sci Rep; 2024 May; 14(1):10583. PubMed ID: 38719848
[TBL] [Abstract][Full Text] [Related]
10. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
Sun L; Feng J; Ma L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
[TBL] [Abstract][Full Text] [Related]
11. Quality Assessment of Prognostic Studies Using Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma.
Teixeira MG; Corrêa L
Appl Immunohistochem Mol Morphol; 2018; 26(5):e61-e69. PubMed ID: 28800012
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive screening of a microRNA-based dysregulation signature in oral cancer and oral potentially malignant disorders.
Yap T; Seers C; Koo K; Cheng L; Vella LJ; Hill AF; Reynolds E; Nastri A; Cirillo N; McCullough M
Oral Oncol; 2019 Sep; 96():113-120. PubMed ID: 31422202
[TBL] [Abstract][Full Text] [Related]
13. SHH Expression Is Significantly Associated With Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma.
Cierpikowski P; Lis-Nawara A; Bar J
Anticancer Res; 2021 Nov; 41(11):5405-5413. PubMed ID: 34732409
[TBL] [Abstract][Full Text] [Related]
14. Salivary
Ueda S; Goto M; Hashimoto K; Imazawa M; Takahashi M; Oh-Iwa I; Shimozato K; Nagao T; Nomoto S
Anticancer Res; 2021 Feb; 41(2):765-772. PubMed ID: 33517281
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Review of MicroRNA Signatures Associated with the Progression of Leukoplakia with and without Epithelial Dysplasia.
Kaunein N; Ramani RS; Koo K; Moore C; Celentano A; McCullough M; Yap T
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944523
[TBL] [Abstract][Full Text] [Related]
16. Immunolocalization of Cancer Stem Cells Marker ALDH1 and its Association with Tumor Budding in Oral Squamous Cell Carcinoma.
Marangon Junior H; Melo VVM; Caixeta ÂB; Souto GR; Souza PEA; de Aguiar MCF; Horta MCR
Head Neck Pathol; 2019 Dec; 13(4):535-542. PubMed ID: 30430416
[TBL] [Abstract][Full Text] [Related]
17. The promise of stem cell markers in the diagnosis and therapy of epithelial dysplasia and oral squamous cell carcinoma.
Mohajertehran F; Sahebkar A; Zare R; Mohtasham N
J Cell Physiol; 2018 Nov; 233(11):8499-8507. PubMed ID: 29797575
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Ovarian Cancer Patients: Evidence from 52 Studies.
Tao Y; Li H; Huang R; Mo D; Zeng T; Fang M; Li M
Cell Physiol Biochem; 2018; 46(4):1716-1726. PubMed ID: 29730663
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of putative cancer stem cell markers (CD24, CD44, CD133, and ALDH1) in human papillary thyroid carcinoma.
Han SA; Jang JH; Won KY; Lim SJ; Song JY
Pathol Res Pract; 2017 Aug; 213(8):956-963. PubMed ID: 28687160
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulators governing cancer stem cells and epithelial-mesenchymal transition in oral squamous cell carcinoma.
Patel S; Shah K; Mirza S; Daga A; Rawal R
Curr Stem Cell Res Ther; 2015; 10(2):140-52. PubMed ID: 25330402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
